Non-vascular drug eluting stents as localized controlled drug delivery platform: Preclinical and clinical experience

2013 ◽  
Vol 172 (1) ◽  
pp. 105-117 ◽  
Author(s):  
Mohsin Shaikh ◽  
Ganessan Kichenadasse ◽  
Namita Roy Choudhury ◽  
Ross Butler ◽  
Sanjay Garg
Author(s):  
Joseph T. Keyes ◽  
Bruce R. Simon ◽  
Jonathan P. Vande Geest

Drug-eluting stents (DESs) perform their antiproliferative effects through the use of localized drug delivery. The delivery may be computationally modeled to determine efficacy of the DES-tissue system and utilizes coupled convective and diffusive transport. Since the movement of solutes through the wall is via the coupled effects of convective and diffusive transport, the relative influence of these factors provides insight into the governing forces of localized DES drug delivery [1].


2014 ◽  
Vol 5 (10) ◽  
pp. 3311-3315 ◽  
Author(s):  
Alexander E. Dunn ◽  
Douglas J. Dunn ◽  
Alexander Macmillan ◽  
Renee Whan ◽  
Tim Stait-Gardner ◽  
...  

A novel theranostic controlled drug delivery platform that binds the drug to the nanocarrier by utilising Schiff base bonds to achieve high spatial and temporal control over drug release.


PLoS ONE ◽  
2015 ◽  
Vol 10 (6) ◽  
pp. e0130182 ◽  
Author(s):  
Franz Bozsak ◽  
David Gonzalez-Rodriguez ◽  
Zachary Sternberger ◽  
Paul Belitz ◽  
Thomas Bewley ◽  
...  

2006 ◽  
Vol 58 (3) ◽  
pp. 412-436 ◽  
Author(s):  
Kalpana R. Kamath ◽  
James J. Barry ◽  
Kathleen M. Miller

RSC Advances ◽  
2019 ◽  
Vol 9 (29) ◽  
pp. 16578-16585 ◽  
Author(s):  
Jonghwan Mun ◽  
Jee won Mok ◽  
Sanghoon Jeong ◽  
Seonghwi Cho ◽  
Choun-Ki Joo ◽  
...  

A cholesterol-hyaluronate (C-HA) micelle embedded contact lens was developed for efficient hydrophobic drug loading and long-term controlled drug delivery.


Sign in / Sign up

Export Citation Format

Share Document